Evaluation of Patients With Immune Function Abnormalities

RecruitingOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

September 19, 2005

Conditions
Chronic Granulomatous Disease (CGD)X-Linked Severe Combined Immune Deficiency (XSCID)Leukocyte Adhesion Deficiency 1 (LAD)Graft Versus Host Disease (cGvHD)
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00128973 - Evaluation of Patients With Immune Function Abnormalities | Biotech Hunter | Biotech Hunter